We are live on ! Find out more
LLY icon

Eli Lilly

3,273 hedge funds and large institutions have $465B invested in Eli Lilly in 2023 Q4 according to their latest regulatory filings, with 438 funds opening new positions, 1,220 increasing their positions, 1,235 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

356% more first-time investments, than exits

New positions opened: 438 | Existing positions closed: 96

10% more capital invested

Capital invested by funds: $422B → $465B (+$42.9B)

10% more funds holding

Funds holding: 2,9753,273 (+298)

1.29% more ownership

Funds ownership: 82.72%84.01% (+1.3%)

1% less funds holding in top 10

Funds holding in top 10: 307305 (-2)

1% less repeat investments, than reductions

Existing positions increased: 1,220 | Existing positions reduced: 1,235

10% less call options, than puts

Call options by funds: $4.99B | Put options by funds: $5.55B

Holders
3,273
Holders Change
+298
Holders Change %
+10.02%
% of All Funds
47.71%
Holding in Top 10
305
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-0.65%
% of All Funds
4.45%
New
438
Increased
1,220
Reduced
1,235
Closed
96
Calls
$4.99B
Puts
$5.55B
Net Calls
-$558M
Net Calls Change
-$245M
Name Holding Trade Value Shares
Change
Change in
Stake
BAM
1276
Belpointe Asset Management
Nevada
$3.02M +$103K +177 +4%
TNAM
1277
Terra Nova Asset Management
New York
$3M +$147K +251 +5%
MMA
1278
Miracle Mile Advisors
California
$3M +$285K +489 +11%
9WM
1279
9258 Wealth Management
Ohio
$2.99M -$3.5K -6 -0.1%
PCA
1280
Peddock Capital Advisors
Massachusetts
$2.98M
CD
1281
Chapin Davis
Maryland
$2.97M +$313K +537 +12%
CSIC
1282
Clifford Swan Investment Counsel
California
$2.96M -$145K -248 -5%
SC
1283
Schulhoff & Co
Ohio
$2.96M -$17.5K -30 -0.6%
ST
1284
Sabal Trust
Florida
$2.96M -$275K -471 -8%
BFM
1285
Boston Financial Management
Massachusetts
$2.95M -$147K -252 -5%
BMCM
1286
Bryn Mawr Capital Management
Pennsylvania
$2.95M +$1.01M +1,732 +52%
SEM
1287
Suncoast Equity Management
Florida
$2.95M +$83.5K +143 +3%
GIM
1288
Gold Investment Management
Alberta, Canada
$2.93M +$2.93M +5,020 New
BW
1289
Bison Wealth
Georgia
$2.92M +$294K +504 +11%
SL
1290
Sentry LLC
Tennessee
$2.92M +$1.17K +2 +0%
P
1291
&Partners
Tennessee
$2.92M +$2.3M +3,944 +380%
JIC
1292
Joel Isaacson & Co
New York
$2.92M +$16.9K +29 +0.6%
SFG
1293
StrategIQ Financial Group
Indiana
$2.91M +$584 +1 +0%
KCM
1294
KRS Capital Management
Michigan
$2.91M +$117K +201 +4%
PP
1295
PDS Planning
Ohio
$2.91M +$5.25K +9 +0.2%
FI
1296
Finivi Inc
Massachusetts
$2.9M +$2.91M +4,977 New
CC
1297
Courier Capital
New York
$2.9M -$223K -382 -7%
TCWA
1298
Turtle Creek Wealth Advisors
Texas
$2.9M +$2.9M +4,969 New
KHLMTHM
1299
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet
Israel
$2.89M
HBT
1300
Heartland Bank & Trust
Illinois
$2.89M -$81.7K -140 -3%

LLY Hedge Fund Activity: Q4 2023 in Review

3,273 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2023, worth a combined $465B — up 10% from $422B a quarter earlier.

Buyers outnumbered sellers: 438 funds opened new LLY positions and 96 closed out — a net gain of 342 holders — while 1,220 added to existing stakes and 1,235 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $7.46B. The largest seller was BlackRock, cutting an estimated $763M.

  • 3,273 institutional investors held Eli Lilly (LLY) as of Q4 2023, up from 2,975 in Q3 2023.
  • Funds reported $465B of Eli Lilly stock for Q4 2023, up 10% quarter-over-quarter.
  • 438 funds opened new Eli Lilly positions in Q4 2023 and 96 closed out, a net change of +342 holders.
  • The largest Eli Lilly buyer in Q4 2023 was Morgan Stanley, an estimated $7.46B added.
  • The largest Eli Lilly seller in Q4 2023 was BlackRock, an estimated $763M sold.

Based on aggregated 13F filings for Q4 2023.